ArticleDiscover oncology2026
Development and validation of a nomogram for predicting progression from multidrug-resistant bacterial colonization to infection in lymphoma patients.
Article in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate the risk factors for progression from multidrug-resistant (MDR) bacterial colonization to infection in hospitalized lymphoma patients and to develop a Nomogram predictive model.
methodsA retrospective analysis was conducted on clinical data from 70 MDR-positive lymphoma patients admitted to a tertiary hospital between March 2017 and March 2025. Patients were divided into MDR infection and MDR colonization groups based on the occurrence of MDR infection. Demographic characteristics, lymphoma subtypes, lesion sites, laboratory parameters, and treatment-related factors were collected. Univariate and multivariate logistic regression analyses were performed to identify independent risk factors, and a Nomogram predictive model was constructed.
resultsAmong 70 MDR-positive patients, 48 (68.6%) developed MDR infection and 22 (31.4%) remained as colonization. Multivariate analysis revealed that T/NK-cell lymphoma (OR = 3.82, 95% CI 1.46–9.98, P = 0.006), nasopharyngeal/nasal cavity involvement (OR = 2.94, 95% CI 1.23–7.04, P = 0.015), recent antibiotic use (OR = 2.67, 95% CI 1.15–6.21, P = 0.022), and albumin < 35 g/L (OR = 2.31, 95% CI 1.08–4.93, P = 0.031) were independent risk factors. The Nomogram model based on these factors demonstrated good discrimination (C-index = 0.812) and calibration.
conclusionT/NK-cell origin, nasopharyngeal involvement, recent antibiotic exposure, and hypoalbuminemia are independent risk factors for progression from MDR colonization to infection in lymphoma patients. The Nomogram model can effectively identify high-risk patients and provide evidence for clinical prevention and control strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.